Observational study to investigate the effects of prostaglandin analogue-induced improved retinal blood flow on the development of visual field damage in patients with preperimetric glaucoma
Not Applicable
- Conditions
- Glaucoma
- Registration Number
- JPRN-UMIN000013733
- Lead Sponsor
- Santen Pharmaceutical Co., Ltd.
- Brief Summary
Aizawa N et.al. PLoS One. 2017;12: e0188692 Shiga Y et.al. Transl Vis Sci Technol. 2018; 7: 11.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients assessed as inappropriate to be enrolled in this observational study by the physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method